Glenmark Pharmaceuticals
Glenmark Pharmaceuticals (India) holds 0 active US FDA Type II Drug Master Files and 4 inactive, has DMF or CEP filings on record for 3 active ingredients and is linked to 4 FDA-registered manufacturing sites. 38 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Glenmark Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/glenmark-pharmaceuticals
Overview
Glenmark Pharmaceuticals is a global innovative pharmaceutical company committed to enriching lives worldwide. Headquartered in Mumbai, India, the company focuses on creating new, affordable therapies in areas like dermatology, respiratory, and oncology.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Glenmark Pharmaceuticals holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Glenmark Pharmaceuticals holds 0 active (4 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- PALONOSETRON HYDROCHLORIDEInactive2010-11-19
- TELMISARTANInactive2005-09-12
- SIMVASTATINInactive2004-12-30
- MFG SITE FACILITIES OPERATING PROCEDURES AND PERSONEL FOR SATPUR NASIK INDIA SITEInactive1999-12-25
Registered manufacturing sites (4)
Physical sites registered with the US FDA and resolved to Glenmark Pharmaceuticals, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- Glenmark Pharmaceuticals LimitedDhar, India · Analytical testing · LabellingSite GMP match
- Glenmark Pharmaceuticals LimitedSolan, India · Analytical testing · LabellingSite GMP match
- Glenmark Pharmaceuticals LimitedChhatrapati Sambhajinagar (previously known as Aurangabad), India · Analytical testing · LabellingSite GMP match
- Glenmark Pharmaceuticals LimitedGoa, India · Analytical testing · LabellingSite GMP match
FDA compliance signals
38 FDA enforcement records linked to this company.
- warning_letter2025-07-11
FDA Warning Letter (drug product)
- 4832025-02-14
Investigations of discrepancies, failures
- 4832025-02-14
Cleaning / Sanitizing / Maintenance
- 4832025-02-14
Approve or reject procedures or specs
- 4832025-02-14
Test methods
- 4832025-02-14
Mfg / Processing Operations Area
- warning_letter2022-11-22
FDA Warning Letter (drug product)
- 4832022-06-22
Failure to meet specifications
- 4832022-06-22
Procedures not in writing, fully followed
- 4832022-06-22
Absence of Written Procedures
- 4832022-06-22
input/output verification
- 4832022-06-22
Investigations of discrepancies, failures
- 4832022-06-22
Cleaning / Sanitizing / Maintenance
- 4832022-05-20
Scientifically sound laboratory controls
- 4832022-05-20
Extent of discrepancy, failure investigations
- 4832022-05-20
Absence of Written Procedures
- 4832022-05-20
Equipment Design, Size and Location
- 4832022-05-20
Prepared for each batch, include complete information
- warning_letter2019-10-03
FDA Warning Letter (drug product)
- 4832019-03-15
Valid stability test methods
- 4832019-03-15
Testing and release for distribution
- 4832019-03-15
Cleaning / Sanitizing / Maintenance
- 4832019-03-15
Approve or reject procedures or specs
- 4832019-03-15
Scientifically sound laboratory controls
- 4832017-11-11
Investigations of discrepancies, failures
- 4832017-11-11
Absence of Written Procedures
- 4832017-11-11
Procedures not in writing, fully followed
- 4832017-11-11
Computer control of master formula records
- 4832017-11-11
Training--operations, GMPs, written procedures
- 4832017-11-11
Records reviewed annually
- 4832017-11-11
Complaint Investigation/Follow-Up Findings
- 4832016-02-26
Written warehousing procedures established/followed
- 4832016-02-26
Computer control of master formula records
- 4832016-02-26
Control procedures fail to include the following
- 4832013-07-19
Written Procedures Not Followed
- 4832013-07-19
Complaint Handling Procedure
- 4832013-07-19
Investigations of discrepancies, failures
- 4832013-07-19
Procedures for non-sterile drug products
Is this Glenmark Pharmaceuticals?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.